This week Lonza took over the reigns of two new US business units
from Cambrex after completing the largest acquisition in its
company history and also announced a capability expansion at its
Czech Republic site.
Pfizer's latest cutbacks will provide a new outsourcing opportunity
for contract manufacturing organisations (CMOs) in low-cost
destinations as the drug giant announces plans to double its amount
of drug production outsourcing.
Cardinal Health is about to sell its drug manufacturing arm to an
international private investment firm, only two months after
announcing its decision to divest the segment, while its second
quarter earnings doubled as a result.
Germany's Vetter Pharma-Fertigung has announced it has obtained a
manufacturing license for its new facility which will expand its
services by adding vial filling for lyophilised (freeze-dried)
products to its portfolio, in addition...
A multi-million dollar US manufacturing contract for Acambis hinges
on whether or not the firm can satisfy the Food and Drug
Administration (FDA) that its investigational smallpox vaccine
should be approved.
A new Special Economic Zone (SEZ) is being created by Indian firm
JB Chemicals & Pharmaceuticals for the contract manufacturing
of active pharmaceutical ingredients (APIs), intermediates and
finished drug formulations.
India's drug manufacturing industry is tipped to grow 10 per cent
over the next three years as more pharma firms shift operations
there to cut costs, says a research report.
Crucell yesterday announced it had received the first orders from
US-headquartered Wyeth Biotech. The order represents the first move
following the finalisation of the contract manufacturing agreement
between the two companies at...
AAIPharma has announced it has signed a contract manufacturing
agreement with Mallinckrodt Pharmaceuticals Outsourcing which aims
to provide a "one-stop drug development solution" for drug makers.
Cardinal Health, the leading contract manufacturer for the
pharmaceutical industry, has announced its plans to sell its drug
manufacturing and packaging unit in order to focus on its
health-care business.
Biotech company Progen has decided to manufacture its new
anti-cancer drug in-house rather than outsource it in order to save
on costs after the FDA gave the thumbs up for the manufacture of
the drug for its upcoming phase III clinical...
Dutch biotech company Crucell said last week that it had completed
its acquisition of SBL Vaccin in an agreement worth €39.4m, but
remained tight-lipped about its plans for the Swedish firm's
contract manufacturing business.
Singapore has successfully completed the first phase of its
biomedical science (BMS) initiative and is now pushing the second
phase forward in order to drive growth in its pharma industry
further.
Drug giant GlaxoSmithKline (GSK) has been awarded a contract with
the US government to supply 800,000 doses of flu vaccine to the US,
where a bird flu pandemic still remains a threat.
Pharma companies struggling to choose a suitable contract
manufacturer to aseptically produce injectable final drug products
(FDP) may now have the support they need thanks to a new guide
released this week.
Lonza has signed two separate deals with California-based Genentech
- a move that illustrates the re-emergence of a relationship
between the two firms.
Germany's Vetter Pharma-Fertigung has announced its plan to expand
its services by adding vial filling for lyophilised - or
freeze-dried - products to its portfolio.
The contract packaging biz is moving from an ad-hoc to a more
strategically determined, long-term approach, as pharma companies
begin to relax in the arms of service providers.
Gerresheimer has announced it will launch a new plastic syringe
range in January to cater for highly-sensitive medications and also
for high-volume injections.
US-based drug maker Cleveland BioLabs has teamed up with
biopharmaceutical manufacturer Synco Bio Partners to produce its
leading radioprotection molecule for clinical trials and
commercialisation
Although manufacturing is the most established of the pharma
outsourcing segments, many service areas are still rapidly
evolving. OutsourcingPharma.com gives a brief run down of the
current state of play.
UK Biopharma company Evolutec has signed a deal with Wacker Biotech
to produce Evolutec's new autoimmune disease drug candidate rEV576
for clinical trials.
Firms engaging in both in-house and contract pharma manufacturing
generally display inferior performance compared to manufacturers
conducting only in-house production, according to new research.
Sigma-Aldrich Group member SAFC made its presence felt at the
recent CPhI in Paris with announcements regarding its expansion
activities in transgenic manufacturing and India.
Injection molder and contract manufacturer Tech Group is relocating
its Grand Rapids plant to a new molding facility in nearby Walker,
Michigan, which will be expanded to cope with the high demand for
medical devices and components.
In a deal worth up to $19.9m (€15.6m), US drug delivery company
Inyx has acquired contract pharmaceutical packaging firm Pharmapac,
seeking to enhance its secondary-packaging capabilities for a wide
range of dosage forms.
Indian biopharmaceutical company Wockhardt has signed a deal with
Maharashtra Industrial Development Corporation (MIDC) to establish
a special economic zone (SEZ) in Aurangabad, India, in order to
expand its manufacturing capabilities.
Following numerous manufacturing failures, Discovery Laboratories
believes it has resolved the stability issues that have plagued
Surfaxin, its experimental respiratory treatment for infants, and
is now seeking a meeting with the...
A majority stake in Irish biotechnology contract services firm
Archport has been snapped up by German-based Chemie Uetikon as the
bio-outsourcing market heats up.
Drug developing services provider Aptuit has acquired the
pharmaceutical services division of technology firm EaglePicher,
enriching its active pharmaceutical ingredient (API) and drug
substance manufacturing offerings.
US contract pharmaceutical manufacturer Metrics has announced a
$17.5m (€13.7m) investment to double the size of its drug testing
and manufacturing plant over the next three years.
Bilcare, India's largest research-based pharmaceuticals packaging
company, has bought UK-based clinical trials services (CTS)
provider DHP in a bid to build itself up to be one of the few
players in this sector with global servicing...
Bang & Olufsen Medicom has unveiled a new disposal
breath-actuated inhaler which uses a reservoir technology that
reduces the daily cost of pulmonary drug delivery.
To escape stagnating growth, hospital supplies firm Hospira has
agreed to buy Australia's Mayne Pharma for $2bn (€1.56bn), creating
the world's biggest manufacturer of generic injectable drugs.
Bentley Pharmaceuticals has announced it will use the North
Carolina facilities of US-based services provider Cardinal Health
for the scale-up and manufacture of the clinical supplies of its
new intranasal insulin product.
Cardinal Health has been given the green light from the US Food and
Drug Administration (FDA) to start manufacturing the first
commercial drug at its new sterile facility in North Carolina.
Kemwell has sealed the deal on the purchase of Pfizer's Swedish
manufacturing plant and at the same time secured a long-term
contract manufacturing agreement with the drug giant.
Successful technology transfer and effective management can help
avoid disappointment with contract manufacturing arrangements,
which often fail to live up to pharmaceutical company expectations.
India's Essel Propack, the largest speciality packaging company in
the world, is acquiring Packaging India Private Limited (PIPL) from
the CavinKare Group, keen to capture more of the country's booming
pharmaceutical packaging...
A good selection process, with a realistic set of selection
criteria is essential when looking for the right contract
manufacturing partner, according to a new Datamonitor report.
